Perk­inElmer re­ceives ap­proval for mass spec­trom­e­try kit

BioSpectrum (India) - - SUPPLIER NEWS -

Perk­inElmer, Inc., a global leader com­mit­ted to in­no­vat­ing for a health­ier world, re­cently an­nounced that its NeoBase 2 Non-Deriva­tized MSMS Kit has re­ceived 510(k) clear­ance from the U.S. Food & Drug Ad­min­is­tra­tion (FDA).

Used with a tan­dem mass spec­trom­e­ter, this in vitro di­ag­nos­tic kit is in­tended for the quan­ti­ta­tive mea­sure­ment and eval­u­a­tion of tra­di­tion­allyscreened amino acids and acyl­car­nitines, as well as suc­ciny­lace­tone, free car­ni­tine, nu­cle­o­side and lysophos­pho­lipid con­cen­tra­tions.

The NeoBase 2 kit mea­sures up to 51 an­a­lytes, in­clud­ing mark­ers for screen­ing of X-linked adrenoleukodys­tro­phy (X-ALD) and adeno­sine deam­i­nase se­vere com­bined im­mun­od­e­fi­ciency (ADASCID). Cur­rently, it is the only mar­ket so­lu­tion that of­fers test­ing for suc­ciny­lace­tone from a dried blood spot punch with a sin­gle ex­trac­tion and in­cu­ba­tion step.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.